alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
April 20, 1982

Mr. A. P. Richard Carden

Regional General Manager

Barclays Bank International Limited 

200 Park Avenue

New York, New York 10166

Dear Mr. Carden:

An article in the American Banker of April 9, 1982, describes 

the plans of Barclays Limited, London, England, to establish a 

subsidiary in London that will place customer and bank orders in 

the Chicago futures market. The subsidiary, Barclays Futures Ltd., 

participate in the London International Financial Futures Exchange, 

at which its business "will be aimed," but it will also execute orders 

on the Chicago Exchange.

As a foreign banking organization with U.S. branches and 

subsidiary banks, Barclays is subject to provisions of the Bank 

Holding Company Act and the Board's Regulations K and Y. Under 

the regulations, Barclays may not engage in any banking or financial 

operations in the United States without the prior approval of the Board. 

In view if these restrictions, Barclays' U.S. offices and subsidiaries 

may not participate in any way in placing orders on the Chicago or 

London Exchanges or in accepting orders from customers for transmittal 

to Barclays Futures without Board authorization. Without such approval, 

these practices would be viewed as engaging in business in the United 

States within the meaning of regulation K and would be impermissible 

under applicable laws.

I would appreciate your confirmation that Barclays will not 

engage in the United States through any U.S. office or subsidiary 

in the activity of acting as a futures broker.

Sincerely,

Michael Bradfield

General Counsel

cc: Federal Reserve Bank of New York

Redacted
```

                                                                   Exhibit 99.3

                           OFFICER'S COMPLIANCE CERTIFICATE

I, David L. Derfelt, a duly authorized representative of Navistar Financial
Corporation,  the Servicer, certify that:

1.   I  have  reviewed  the  annual  report  and  other  reports  containing
        distribution information for the period covered  by the  annual report;

2.      To the best of my knowledge, no untrue statements of material fact exist
        in these reports, and no material facts were omitted.

3.      These reports include to the best of my  knowledge, the
        financial information required to be provided to the trustee under the
        governing documents of the Issuer; and

4.      The Servicer is compliant with its servicing  obligations and minimum
        servicing standards except as detailed below.

5.      No default in performance of any obligations has occurred.

6.      The Company  did  not comply  with  the requirements that custodial bank
        account  and  related  bank clearing account reconciliations be reviewed
        and  approved  by someone  other  than  the   person  who  prepared  the
        reconciliation,  and  that  they be  prepared  within 45 days after  the
        cutoff  date  as  specified  in  items I.1.b and I.1.c in USAP's minimum
        servicing standards.

     Date: January 26, 2009           By:/s/DAVID L. DERFELT
                                            David L. Derfelt
                                            V.P., and Controller
                                           (Principal Accounting Officer)
```
OPINION I IS A CONFERENCE OPINION AND IS NOTACCESSIBLE THROUGH THE ARCHIVES AND RECORDS OFFICE.
<PAGE>
                                                                 Exhibit 10.46


                                 AMENDMENT NO. 2

       This Amendment No. 2 dated as of July 9, 1999, is made by and among
EPIX MEDICAL, INC., a Delaware corporation having its principal place of
business at 71 Rogers Street, Cambridge, Massachusetts 02142-1118 U.S.A.
("Epix"), MALLINCKRODT MEDICAL, INC., a Delaware corporation having its
principal place of business at 675 McDonnell Boulevard, St. Louis, Missouri
63134, and MALLINCKRODT INC. (under its prior corporate name MALLINCKRODT
GROUP INC.), a New York corporation having its principal place of business at
7733 Forsyth Boulevard, St. Louis, Missouri 63105, by and through its
unincorporated Mallinckrodt Imaging Group (together with Mallinckrodt
Medical, Inc., "MKG").

                                   RECITALS

       WHEREAS, Epix (under its prior corporate name Metasyn, Inc.) and MKG
are parties to a Strategic Collaboration Agreement dated as of August 30,
1996 and amended pursuant to Amendment No. 1 as of September 10, 1998 (the
"Collaboration Agreement"); and

       WHEREAS, Epix and MKG desire to further amend the Collaboration
Agreement, as set forth herein.

       NOW THEREFORE, in consideration of the premises Epix and MKG mutually
agree as follows:

                                ARTICLE I. AMENDMENT

       Epix and MKG hereby agree to amend Section 2.2 of the Collaboration
Agreement so that Section 2.2, as amended and restated, reads in its entirety
as follows:

       2.2  [ * ].  In the event that during the term of this Agreement Epix
[ * ]. In such event, Epix shall [ * ]. Epix shall [ * ],

[ * ] Omitted portions filed separately with the Securities and Exchange
      Commission.


<PAGE>

Epix and MKG shall [ * ]. If, [ * ], Epix and MKG [ * ], then, unless
the Parties [ * ], Epix shall [ * ].

                          ARTICLE 2. MISCELLANEOUS

       Except as expressly amended by this Amendment No. 2, the Collaboration
Agreement shall remain unmodified and in full force and effect. This
Amendment No. 2 may be executed in two or more counterparts, each of which
shall be deemed an original, but all of which together shall constitute one
and the same instrument. This Amendment No. 2 shall be governed and construed
in accordance with the laws of the State of New York without giving effect to
the choice of law provisions thereof.

       IN WITNESS WHEREOF, the Parties have executed this Amendment No. 2 as
of the date set forth above.


EPIX MEDICAL, INC.                        MALLINCKRODT MEDICAL, INC.

By: /s/ Michael D. Webb                   By: /s/ Bradley J. Fercho
   -----------------------                   ------------------------
Name:  Michael D. Webb                    Name:  Bradley J. Fercho
Title: President and Chief                Title: President, Mallinckrodt
       Executive Officer                         Imaging Group


[ * ] Omitted portions filed separately with the Securities and Exchange
      Commission.
Exhibit 32.2  CERTIFICATION BY CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Annual Report of TAL International Group, Inc. (the Company) on Form 10-K for the period ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, John Burns, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:  (1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  /s/  John   BurnsJohn BurnsSenior   Vice President and Chief Financial OfficerDate: February 18, 2011